D.E. Shaw & Co’s Oscar Health OSCR Stock Holding History

D.E. Shaw & Co’s Portfolio OSCR Stock Details OSCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.7M	Buy	930,700 +270,700	+41%	+$3.81M	0.01%	1580
2025 Q4	$9.48M	Sell	660,000 -149,300	-18%	-$2.58M	0.01%	1804
2025 Q3	$15.3M	Buy	+809,300	New	+$13.3M	0.01%	1363
2023 Q1	–	Sell	-60,000	Closed	-$148K	–	4747
2022 Q4	$148K	Hold	60,000	–	–	﹤0.01%	4319
2022 Q3	$299K	Hold	60,000	–	–	﹤0.01%	4302
2022 Q2	$255K	Hold	60,000	–	–	﹤0.01%	4433
2022 Q1	$598K	Hold	60,000	–	–	﹤0.01%	4258
2021 Q4	$471K	Buy	+60,000	New	+$753K	﹤0.01%	4439

Other funds holding OSCR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

TCMNY

Thrive Capital Management (New York) New York $344M AUM 25.6% 1-Year Est. Return

BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co's OSCR Position: Q1 2026 in Review

D.E. Shaw & Co reduced its Oscar Health (OSCR) stake by 9.9% in Q1 2026, selling an estimated $8.48M and leaving 5,485,285 shares worth $62.9M. The position accounts for 0.04% of the portfolio, ranked #566.

D.E. Shaw & Co first reported a position in OSCR in Q1 2022 and has held it in 16 quarters since. The position peaked at $87.5M in Q4 2025. 330 funds tracked by Wall St. Rank hold OSCR as of Q1 2026.

D.E. Shaw & Co held 5,485,285 shares of Oscar Health worth $62.9M as of Q1 2026.
D.E. Shaw & Co sold 602,077 Oscar Health shares in Q1 2026, an estimated $8.48M.
Oscar Health made up 0.04% of D.E. Shaw & Co's portfolio in Q1 2026, its #566 holding.
D.E. Shaw & Co first reported a position in Oscar Health in Q1 2022 and has held it in 16 quarters since.
D.E. Shaw & Co's Oscar Health position peaked at $87.5M in Q4 2025.
330 funds tracked by Wall St. Rank held Oscar Health as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.